Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4013220016 | Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4013221017 | Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Plays role | Antiviral therapeutic role | true | Inferred relationship | Some | ||
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Is a | Glecaprevir and pibrentasvir only product in oral dose form | true | Inferred relationship | Some | ||
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 1 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has precise active ingredient | Pibrentasvir | true | Inferred relationship | Some | 1 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has BoSS | Pibrentasvir | true | Inferred relationship | Some | 1 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has BoSS | Glecaprevir | true | Inferred relationship | Some | 2 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has precise active ingredient | Glecaprevir | true | Inferred relationship | Some | 2 | |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR